Abstract Epigenetic mechanisms are of interest as therapeutic targets in photocarcinogenesis as they are reversible. Evidence derived from mouse models of ultraviolet radiation-induced skin carcinogenesis and other photocarcinogenesis models suggests that these changes can be controlled or prevented by phytochemicals derived from dietary plants. Thus, improved knowledge of the potential e f f e c t s o f g r e e n t e a p o l y p h e n o l s ( G T P s ) a n d proanthocyanidins from grape seeds (GSPs) on epigenetic processes may be useful for the chemoprevention of skin cancers which are a major public health concern. In the present article, we provide a short review of epigenetic regulatory mechanisms in mammals and examine the impact of two natural substances, GTPs, and GSPs, on these epigenetic processes.
Introduction
The incidence of skin cancer, including melanoma and nonmelanoma, is equivalent to the incidence of malignancies in all other organs combined [1] , and it has been estimated that the cost of treating skin cancers in the USA is approximately $3.0 billion annually [2] . New approaches to the prevention of skin cancers are needed urgently to alleviate the burden of this major public health problem. It is increasingly apparent that epigenetic events play a critical role in cancer. The initiation and progression of skin cancers specifically has been linked to alterations in DNA methylation and histone modifications that lead to the silencing of key tumor suppressor genes [3] [4] [5] .
best characterized [2, 3] . These epigenetic mechanisms play critical roles in normal development and affect gene expression in many biological processes, such as genomic imprinting and DNA repair, as well as contributing to DNA mutation [6] [7] [8] [9] . In mammals, the DNA methylation of cytosine located 5′ to guanosine in a cytosine and guanosine (CpG) dinucleotide is of particular importance [10, 11] . CpG dinucleotides are often clustered in CpG-rich regions of DNA, known as CpG islands. Notably, these CpG islands are frequently associated with the transcription start site [11, 12] . Approximately 70-80 % of the CpGs in the mammalian DNA are methylated in the 5′-regulatory region, and 5-methylcytosine can occasionally be found in CpG dinucleotides in mammals [3] [4] [5] 13] . This DNA methylation mechanism is normally involved in transcriptional silencing of genes and silencing of genes located on the inactive X chromosomes [6, 14] .
DNA Methylation
Carcinogenesis has been shown to be associated with global DNA hypomethylation and with regional hypermethylation [4, 5] . The carcinogenic effects of the DNA hypomethylation and hypermethylation are mediated in large part by silencing of tumor suppressor genes, upregulation of oncogenes, and/or decreased genomic stability [13, 14] and, potentially, the contribution of DNA methylation to DNA mutation [6] [7] [8] [9] . DNA hypermethylation, usually occurring at promoter CpG islands, is a major epigenetic mechanism in silencing the expression of tumor suppressor genes [10, [15] [16] [17] . The importance of promoter hypermethylation as well as global hypomethylation in carcinogenesis has been recognized [10, [16] [17] [18] . Several investigations have found that approximately half of tumor suppressor genes are inactivated in sporadic cancers and that this is medicated more often by epigenetic mechanisms than by genetic mechanisms. Several genes with tumor suppressor properties in mouse models are inactivated exclusively by epigenetic mechanisms in human neoplasia [19, 20] , and it has been recognized that epigenetic changes occur very early in neoplastic lesions and precede epithelial malignancy [21] [22] [23] . Overall, there is a strong evidence that the neoplastic phenotype in many cases is due to epigenetic-based pathway alterations. Thus, the genetic information provides the guidelines for the synthesis of all the proteins necessary for a living organism while the epigenetic information provides instructions on when, where, and how the genetic information should be used for this purpose [3] [4] [5] .
The addition of methyl groups is mediated by DNA methyltransferases (Dnmts). Of the members of the Dnmt family, three (Dnmt1, Dnmt3a, and Dnmt3b) are required for DNA methylation. Normally, Dnmt1 acts primarily to maintain the established DNA methylation pattern, whereas Dnmt3a and Dnmt3b are involved primarily in new or de novo DNA methylation. In diseased cells, including cancer cells, however, Dnmt3b may cooperate with Dnmt1 in maintaining the established abnormal gene hypermethylation patterns. Dnmts have been shown to be overexpressed in cancer [11] . Finally, the methylation of cytosine has been shown to dramatically enhance pyrimidine dimer formation after exposure of the cells to ultraviolet (UV) radiation. This has been attributed to the higher energy absorption of the 5-methylcytosine (5-mC) as compared to the cytosine in the DNA. As many of the signature mutations occur at CpG sites [24] , the presence of 5-mC in DNA may add to the UVB-associated mutational burden through different mechanisms [3, 5, 9] .
Hypermethylation often occurs in the context of DNA damage and has been associated with cancer and agingassociated conditions. It may act to silence genes by promoting a repressive chromatin environment. Specifically, hypermethylation of the CpG dinucleotides located near the transcriptional regulatory regions may facilitate the recruitment of proteins with methyl-CpG binding domains, including the MeCp2 and MBD1, that further recruit histone deacetylases (HDAC) [25, 26] . This mechanistic pathway suggests how UV irradiation-induced DNA hypermethylation can affect chromatin assembly leading to the suppression or silencing of tumor suppressor genes as illustrated in Fig. 1 .
Histone Modifications
Histones are susceptible to modifications of crucial lysine, arginine, and serine residues. These modifications result in changes in the chromatin structure that regulates access of transcriptional activators and/or repressors to the gene promoters. Thus, histones are central to the regulation of gene expression [27] [28] [29] . The enzymes involved in histone modification have been characterized extensively and include acetylation on specific lysine residues by histone acetyltransferases (HATs), deacetylation by HDACs, methylation of lysine and arginine by histone methyltransferases (HMTs), demethylation of lysine residues by histone demethylases (DMTs), and phosphorylation of specific serine groups by histone kinases [30] . It is well established that histone phosphorylation has important functions in mitosis, genomic stability, and cell proliferation [12] . Notably, certain histone modifications appear to function as "codes" that can determine the ultimate cellular outcome. That is, depending on the protein that recognizes the "code," specific downstream events are initiated that determine, for example, whether transcriptional activation or repression occurs.
Histone modifications have been implicated in tumorigenesis [27] [28] [29] , and aberrant histone phosphorylation is a common event in many cancers [31] . Histone deacetylases can act to eliminate the acetylation marker resulting in transcriptional repression, which is particularly important in determining the function of tumor suppressors. For example, deacetylation of histones at the promoter region of Cip1/p21 results in silencing of this tumor suppressor gene and promotes tumorigenesis [32, 33] . This deacetylation event can occur due to either lack of functional HAT or enhanced HDAC activity [32, 33] . It has been suggested that aberrant enrichment of HDAC and HAT activities also may trigger carcinogenesis [34, 35] . In these circumstances histone hyperacetylation at certain promoters results in activation of genes that are normally repressed rather than transcriptional inactivation [34, 36] . The methylation status of histones also can affect transcription. Histone methylation is catalyzed by histone methyltransferases, and removal of methyl groups is catalyzed by the histone demethylases (HDMs) [37] . It has been demonstrated that the histone demethylase, which mediates H3-K4 demethylation, leads to transcriptional repression. The core histones and histone H1 undergo phosphorylation on specific serine and threonine residues by H1 and H3 kinases.
Effect of UV Radiation on Epigenetic Regulators
Epigenetic regulators play a central role in linking environmental cues and cellular responses. It is well established that various environmental factors, such as chronic exposure of the skin to solar UV radiation, contribute to the development of skin cancer. The sustained inflammation, oxidative stress, and DNA damage that are elicited by chronic exposure to UV radiation have been shown to have significant effects on epigenetic mechanisms. For example, chronic inflammation accelerates DNA methylation changes [38] .
Given the number of responses affected by UV radiation and their potential effects on regulation of epigenetic mechanisms, a number of investigators have focused on the global effects of UV radiation on epigenetic regulators. Analysis of the promoter methylation status of genes in basal cell carcinoma and squamous cell carcinoma lesions of the skin revealed a high frequency of methylation of several known tumor suppressor genes, including CDH1, CDH3, LAMA3, LAMC2, RASSF1A, etc. [39] . Epigenetic abnormalities also have been observed in cutaneous squamous cell carcinomas along with frequent inactivation of the RB1/p16 and p53 pathways, although the epigenetic abnormalities associated with p53 expression remain unclear [40] . Nandakumar et al. undertook a systematic analysis of UV-exposed skin and UV-induced skin tumor samples from mice in terms of DNA methylation and histone modifications [41•] . The results indicate a pattern of UV exposure induction of DNA hypermethylation in both the epidermis of the skin and the UV-induced skin tumors. In addition, the levels of Dnmts in the UV-exposed mouse skin and UV-induced skin tumors were enhanced. A distinct distribution pattern of Dnmt1, Dnmt3a, and Dnmt3b in the UVBexposed skin and a preferential distribution of Dnmt3a-positive and Dnmt3b-positive cells in the basal layer of the UVB-exposed skin was observed. This suggests the possibility that de novo synthesis of Dnmt3a and Dnmt3b may act to induce a chromatin marker that is associated with proliferation on UVB-exposure of the skin and within UVB-induced skin tumors. Both the increase in the levels of global DNA methylation and the increase in the levels of Dnmt activity were found to occur in the UV-exposed skin and at a relatively stage, prior to the appearance of skin tumors. This suggests that these epigenetic effects contribute to the process of carcinogenesis. Although DNA hypomethylation has been reported to be present in the skin of UV-exposed mice, it was observed in infrequent sporadic patches of skin, whereas DNA Fig. 1 UVB irradiation-induced DNA hypermethylation in chromatin assembly of skin cells induces recruitment of methyl-binding proteins which further recruit HDAC. This process leads to deacetylation of histones. This whole process leads to transcriptional downregulation of tumor suppressor genes. Treatment with green tea polyphenols (GTPs) or grape seed proanthocyanidins (GSPs) inhibits or delays these epigenetic processes and thus contributes to the prevention of skin cancer hypermethylation was observed throughout the UV-irradiated skin.
As described above, DNA hypermethylation and histone hypoacetylation may promote carcinogenesis and tumorigenesis through downregulation of tumor suppressor genes [42, 43] . UVB exposure leads to transcriptional silencing of the p16
INK4a and RASSF1A, and this has been associated with hypoacetylation of H3 and H4 histones [41• ]. An increase in the recruitment of MeCP2 and methyl-CpG-binding domain 1 to the p16
INK4a and RASSF1A methylated heterochromatin also was observed on chronic exposure of mouse skin to UVB radiation. Thus, these studies suggest involvement of MeCP2 and methyl-binding domain 1 in the chromatin remodeling and transcriptional silencing of the tumor suppressor genes p16
INK4a and RASSF1A on chronic UV exposure. They also suggest a link between DNA methylation and histone acetylation in the effects of chronic exposure to UV irradiation. Finally, this study demonstrated that chronic exposure of the mouse skin to UV radiation stimulates the expression and activity of Dnmts, which may lead to the aberrant hypermethylation of DNA in skin cells. These events are associated with the downregulation of tumor suppressor genes, most likely through the formation of closed chromatin structure. The clinical relevance of these studies is suggested by the analysis of human samples of squamous cell carcinoma, which showed higher levels of DNA hypermethylation, global DNA methylation, and increased DNMT activity than normal human skin samples. These investigations and their outcomes support the clinical significance of the role of epigenetic modifications in cutaneous diseases associated with UVB radiation exposure to the skin and suggest that these epigenetic modifications in skin contribute to the cutaneous malignancies in UVexposed skin. As most of the epigenetic modifications are reversible, targeting of these events may lead to the development of appropriate therapeutic strategies for the treatment of nonmelanoma skin cancers caused by UV irradiation. These epigenetic strategies could be achieved through the use of demethylating agents or inhibitors of histone deacetylation, which would correct aberrant DNA hypermethylation patterns in the skin exposed to UV radiation and that can restore normal growth in skin cells. Bioactive dietary phytochemicals offer promising options for the development of effective epigenetic mechanism-based chemopreventive strategies for the non-melanoma skin cancers, including squamous cell carcinoma and basal cell carcinoma.
Effect of Dietary Phytochemicals on UV-Induced Epigenetic Regulators: Emphasis on Green Tea Polyphenols and Proanthocyanidins From Grape Seeds
In recent years, there has been an increasing awareness and considerable interest in the use of plant products, including dietary components, for medicinal purposes. This interest is fueled by the centuries-old observations of the association of diet and health. Indeed, most of the chemotherapeutic drugs currently prescribed for cancer treatment were originally derived from natural plant sources based on folklore [44, 45] . Although considered a promising area of investigation, the scientific analysis of the role of bioactive food components in the treatment or prevention of diseases, including cancer, remains understudied. In terms of UV radiation-induced cutaneous malignancies and associated skin diseases, the scientific analysis of the effects of plant products is beginning to offer promising new options. UVB-induced skin cancer represents one cancer disease in which the primary triggering environmental cue has been identified and, thus, development of more effective chemopreventive strategies could have a disproportionate effect on health care. In the context of chemoprevention and the necessary considerations concerning potential toxicities, plant products that are already widely used in the diet are of particular interest. As is evident from the available literature and as summarized above, DNA hypermethylation leads to the epigenetic modulation and histone modifications in the genome, which leads to the initiation of disease including the risk of cancers [3] [4] [5] . Thus, if any bioactive component has the capability to inhibit UV radiation-induced DNA hypermethylation or able to reverse this process, then it will be considered as a change in a right direction and favors human health.
Proanthocyanidins are oligomers or polymers of polyhydroxy flavan-3-ol units, such as (+)-catechin and (−)-epicatechin [46] that are found in the fruits, vegetables, nuts, seeds, and flowers, as well as the bark, of several plants. A particularly rich source of proanthocyanidins is grape seeds, in which proanthocyanidins represent 60-70 % of the seed content. Grape seeds are included in the diet of some cultures. Supplementation of the AIN76A control diet with grape seed proanthocyanidins (GSPs) has been shown to inhibit the growth of UV radiation-induced skin tumors in mice [47] . The GSPs reduce the UV-induced inflammatory responses, reduced the levels of inflammatory mediators, and alleviated oxidative stress, and these effects have been demonstrated to be associated with the inhibition of tumorigenesis [48, 49] . The ability of the GSPs to target so many responses in different strains of mice and in the context of an environmental trigger suggested the possibility that they may act through epigenetic mechanisms. This possibility is now supported by analyses of epigenetic regulators in UVB-exposed skin and UVB-induced skin tumors.
Provision of GSPs in the diet reduced the levels of UVBinduced global DNA methylation in the skin and in skin tumor samples. Moreover, a reduction in the levels of 5-mC and Dnmt activity was observed. Concomitantly, the levels of tumor suppressor genes, including Cip1/p21 and p16
INK4a
, were enhanced or restored in both chronic UVB-exposed skin and UVB-induced skin tumors of mice fed GSPs (0.5 %, w/w) as compared with control animals that did not receive GSPs. Collectively, these data are consistent with a model in which the ability of dietary GSPs to prevent the development of UVB-induced skin tumor development is associated with the ability of the GSPs to modulate epigenetic effects. Green tea catechins or green tea polyphenols (GTPs) from the plant Camellia sinensis have been studied extensively using both in vitro and in vivo models. Reports from the author's laboratory and from others have demonstrated clearly that GTPs are effective cancer chemopreventive agents [Reviewed in [50, 51] ]. For example, provision of GTPs in drinking water (0.2 %, w/v) significantly inhibited UVB-induced skin tumor development in mice [52] . Moreover, provision of a water extract of green tea leaves, either caffeinated or decaffeinated, prevents UV-induced skin tumorigenesis in mice [53, 54] . In other studies, it has been shown that topical application of (−)-epigallocatechin-3-gallate (EGCG) inhibits UVB-induced inflammatory responses and oxidative stress, as well as photocarcinogenesis in laboratory animals [55, 56] . The prevention of UV-induced skin tumor development in mice either by administration of GTPs in drinking water or topical application of EGCG has been shown to be associated with the c o n t r o l o f c e l l c y c l e r e g u l a t o r y c h e c k p o i n t s , hyperproliferation, and inflammatory mediators [56] [57] [58] [59] . A potential link between the chemopreventive effects of EGCG specifically the modulation of epigenetic effects was suggested by EGCG-induced DNA hypomethylation in UVB-exposed skin, although this effect was sporadic [55] . Studies from the author's laboratory suggest that provision of GTPs (0.2 %, w/v) in the drinking water of mice for approximately 24 weeks inhibited chronic UVB exposureinduced DNA hypermethylation and the activity of Dnmts in mouse skin. Moreover, in UVB-induced skin tumors, HDAC activity was lower and the tumor suppressor genes, Cip1/p21 and p16
, were reactivated in mice provided GTPs in the drinking water as compared to the UVB-induced tumors in mice provided plain water [60••] . The epigenetic mechanisms related to skin cancer and the impact of green tea polyphenols on these processes have also recently been discussed by Saha et al. [61] .
The potential clinical relevance of these studies is suggested by the work of Nandakumar et al., [60••] , who have examined epigenetic regulation by tea catechins and elucidated the underlying mechanisms using the A431 and SCC13 human skin carcinoma cell lines as an in vitro model system. Their comparative characterization of the tea catechins indicated that (−)-epicatechin-3-gallate and EGCG are comparatively better epigenetic modulators than the other tea epicatechins. Their results indicated that EGCG acts like an inhibitor of DNA methylation as the treatment of A431 and SCC13 cells with EGCG for 6 days resulted in a significant decrease in the levels of global DNA methylation, 5-mC in DNA, and the Dnmt activity [60••] . The effects of EGCG on A431 cells paralleled those 5-Aza-2′-deoxycytidine (5-Azadc), a known inhibitor for DNA methylation, in terms of global DNA methylation as well as the activity and messenger RNA (mRNA) and protein expression of DNMT1, DNMT3a, and DNMT3b.
The effects of EGCG on histone acetylation also have been analyzed. As described above, histone deacetylation converts the normally open chromatin structure to a closed chromatin structure that is associated with transcriptional repression [62] . Thus, histone modifications have been variously linked to either transcriptional activation or transcriptional repression of genes [62] . Treatment of skin cancer cells with EGCG has been found to significantly decrease HDAC activity, which play a key role in regulation of histone deacetylation. The most common histone modifications involved in epigenetic repression of genes are deacetylation and methylation of H3-Lys 9 [63] , which occur in a slow and time-dependent manner. Treatment of cells with EGCG decreased the levels of methylated H3-Lys 9 while increasing the levels of acetylated H3-Lys 9 and H3-Lys 14. These effects were similar to those of trichostatin A, an HDAC inhibitor [60••, 64••] . It also appears that the effects of EGCG mirror those of 5-Aza-dc, a methyltransferase inhibitor, and prevent histone methylation. The additional ability of EGCG to increase acetylation of H4-Lys 5, H4-Lys 12 and H4-Lys 16 in the skin cancer cell lines also may contribute to the transcriptional activation of tumor suppressor genes. Collectively, these studies reveal that EGCG affects multiple epigenetic mechanisms or regulators, including DNA demethylation and modifications of histone acetylation and methylation. These effects may underlie the anti-carcinogenic effects of EGCG through their role in reactivation or re-expression of mRNA associated with tumor suppressor genes. The specific demonstration of restoration of p16 INK4a and Cip1/p21 in human skin cancer cells suggests that this reactivation of tumor suppressor genes may contribute to the suppression of cancer cell proliferation and induction of apoptosis. The epigenetic regulation of the p53 tumor suppressor gene in UV-induced skin carcinogenesis has not yet been fully elucidated [39] . Most recently, Henning et al. [65••] have reported that EGCG has the ability to alter DNA methyltransferase activity in skin cancer cells and that this can contribute to the chemopreventive effect of green tea.
Conclusion
These studies clearly indicate that an understanding of epigenetic effects is of considerable importance in developing an understanding of the anti-photocarcinogenic effects of dietary bioactive components. Several critical questions remain, however. It is now apparent that the phytochemicals may affect multiple epigenetic mechanisms. Their effects on microRNAs (miRNAs), a newly described class of small, non-coding RNAs, have not yet been explored. miRNAs can regulate gene expression by binding to the 3′-untranslated regions (3′-UTRs) of specific mRNAs [66, 67] . They are commonly expressed in cancer and have been shown to play crucial roles in the development and progression of cancer, functioning either as oncogenic miRNAs or as tumor suppressor miRNAs [68, 69] . The list of cellular responses regulated by miRNAs continues to grow and includes cell proliferation, differentiation, and apoptosis. Notably, each miRNA has the potential to target hundreds of genes due to seed region complementary sites in their 3′-untranslated regions [70] . Clinical application, however, requires additional in vivo animal studies that will address the full scope of the effects of the phytochemicals on epigenetic regulation, their temporal associations, and the prime molecular targets of phytochemicals in the chemoprevention of UV radiation-induced skin cancer on different genetic backgrounds. As the epigenetic changes are reversible, such studies may also lead to the development of epigenetic-based novel chemopreventive and therapeutic strategies to prevent nonmelanoma skin cancers in humans.
